Mesa Laboratories MLAB
$127.93 −$5.48 (-4.11%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $127.93 0.00%
Open$131.62
Prev close$133.41
Day range$126.73 – $134.00
Volume76.0K
Market cap$719.03M
P/E (TTM)110.3
Dividend yield0.50%
Earnings
Average move on report day±7.0%last 16 reports
Closed higher8 of 1650% of the time
Best reaction+11.0%
Worst reaction-24.9%
Stock move on the day after each report
| Quarter | Report date | Timing | Implied move | Actual move | Versus implied |
|---|---|---|---|---|---|
| 2027/Q2 | 9 Nov 2026 | After Market | – | +7.11% | – |
| 2027/Q1 | 10 Aug 2026 | None | – | -1.00% | – |
| 2026/Q4 | 27 May 2026 | Pre Market | – | -14.48% | – |
| 2026/Q3 | 3 Feb 2026 | Pre Market | – | +8.73% | – |
| 2026/Q2 | 6 Nov 2025 | After Market | – | +1.52% | – |
| 2026/Q1 | 5 Aug 2025 | Pre Market | – | -24.92% | – |
| 2025/Q3 | 4 Feb 2025 | Pre Market | – | +2.49% | – |
| 2024/Q4 | 31 May 2024 | Pre Market | – | -13.28% | – |
| 2024/Q3 | 5 Feb 2024 | Pre Market | – | +5.64% | – |
| 2024/Q2 | 6 Nov 2023 | Pre Market | – | -1.41% | – |
| 2024/Q1 | 3 Aug 2023 | Pre Market | – | +5.23% | – |
| 2023/Q4 | 25 May 2023 | Pre Market | – | -1.97% | – |
| 2023/Q3 | 6 Feb 2023 | Pre Market | – | -9.08% | – |
| 2019/Q3 | 4 Feb 2019 | Pre Market | – | +1.42% | – |
| 2018/Q3 | 5 Feb 2018 | After Market | – | -3.32% | – |
| 2016/Q4 | 2 Jun 2016 | None | – | +11.01% | – |
"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.
Where the revenue comes from
Quarter 2027/Q2
By business line
Fundamentals
Latest reported quarter: Q2, ended Sep 2026
Revenue$62.34M+2.6% YoY
Operating profit$8.39M+77.6% YoY
Net profit$4.34M+75.3% YoY
Diluted EPS$0.75+66.7% YoY
Free cash flow$3.71M-48.0% YoY
Operating cash flow$4.10M
Revenue, last 8 quarters
Net profit, last 8 quarters
Profitability & balance sheet
Gross margin64.8%
Operating margin10.4%
Net margin2.7%
Return on equity3.6%
Return on assets1.6%
Return on invested capital3.7%
Current ratio1.90
Liabilities / assets52.3%
Cash & investments$22.31M
Total debt$131.51M
Net cash (debt)-$109.19M
Free cash flow / sales19.7%
No comments yet — be the first to weigh in on MLAB.
Sign in to join the discussion.